Home Archive Vol.40, No.1, 2014 Pharmacological Mechanisms Underlying the Association of Antipsychotics with Metabolic Disorders

Pharmacological Mechanisms Underlying the Association of Antipsychotics with Metabolic Disorders

Ileana Cristina Miron(1), Victoriţa Cătălina Baroană(1), Florica Popescu(2), Floriana Ionică(3)

(1)Ph.D. Student in Pharmacology, University of Medicine and Pharmacy of Craiova, (2)Pharmacology Discipline, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, (3)Pharmacology Discipline, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova

    Abstract: Obesity and metabolic syndrome in association with an increased risk of cardiovascular disease and type II diabetes are significant problems that contribute to lower life expectancy of patients with schizophrenia. Understanding the pharmacological mechanisms of the current antipsychotic treatment is clearly the key to the improvement of pharmacotherapy, to avoid or to mitigate the metabolic adverse effects.
    Keywords: antipsychotic, pharmacological mechanisms, metabolic disorders.

DOI 10.12865/CHSJ.40.01.02


All articles in this issue

Volume 40 Issue 1 2014